twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives
Click here for more information about Liqofluxphenometrics515R1
Visit cricatalyst.com!Readers Poll

Research

Study: red seaweed slows cancer growth

February 10, 2017
AlgaeIndustryMagazine.com

Kappaphycus alvarezii, or elkhorn sea moss, is a species of red algae, and one of the most important commercial sources of carrageenans. Photo: courtesy quazoo.com

Mae Chan writes in RiseEarth.com about a recent study in Malaysia that found Kappaphycus alvarezii red seaweed helps in slowing down the growth rate of mammary tumors – which researchers say displays the alga’s potential as a natural aid in cancer treatment.

K. alvarezii is an algae species cultivated for its nutrients and nutraceutical uses in South East Asia. It is an important source of kappa carrageenan, a hydrocolloid used as food additive — acting as a gelling, emulsifying, thickening and stabilizing agent in both pharmaceutical and nutraceutical products.

The red seaweed has significant amounts of protein, vitamins, trace elements and a wide range of second metabolites not found in other organisms. Most importantly, it has antiproliferative properties — or the ability to inhibit cell growth.

To determine if K. alvarezii extract can slow down growth of cancer cells, researchers from the USCI University in Malaysia tested it on rats induced with mammary tumors by using DMBA, a powerful organ-specific laboratory carcinogen.

Twenty rats were divided into three groups: experimental, untreated, and normal, plus control groups. Both experimental and untreated groups received DMBA, with the experimental group receiving K. alvarezii crude extracts orally, and only after tumors developed.

An MTT assay determined if the cancer cells induced in the rats would be able to survive following treatments of various concentrations of K.alvarezii. The concentrations used during the study were 1.0 mg/mL, 3.0 mg/mL, 5.0 mg/mL, 7.0 mg/mL, 9.0 mg/mL, 12.0 mg/mL and 15.0 mg/mL respectively.

Researchers noted that K.alvarezii administered at 1.0mg/mL started inhibiting cell growth, and showed a reduction of cells compared to the solvent control.

“The percentage of cell viability of MCF-7 (breast cancer cells) was reduced from 84.91% to 0.81% which showed a significant reduction of cell viability when the concentration of K. alvarezii extract is increased,” they wrote. “Based on the observation, K. alvarezii extract is able to induce the apoptosis of the MCF-7.”

Read More

More Like This…

HOME A.I.M. Archives

Copyright ©2010-2017 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

Visit our 2017 International Reader’s Poll Platinum Sponsors

bigelow mbiolp_link sfcc

From The A.I.M. Archives

— Refresh Page for More Choices
Portuguese microalgae producer, Allmicroalgae Natural Products S.A., has moved to the next stage in development of new production technologies to grow Nannochloropsis oce...
Forbes is running an interview with Bren Smith, an Ashoka Fellow and the founder of GreenWave, an organization dedicated to restoring oceans, mitigating climate change an...
Algatechnologies Ltd (Algatech), of Kibbutz Ketura, Israel, has become part of the FoodConnects consortium, as winner of a pan-European competition for the Food4Future pr...
The Energy Department (DOE) has announced the selection of six projects for up to $12.9 million in federal funding, entitled, “Project Definition for Pilot- and Demonstra...
Discovering which algae species is best suited to make biofuel is no small task. Researchers have tried to evaluate algae in test tubes, but often find lab results don’t ...
Kailua-Kona, Hawaii-based Cellana, Inc., a leading developer of algae-based products for sustainable nutrition and energy applications, and Living Ink Technologies of Den...